In 2002, revenues of pharma products which utilize advanced drug delivery technology reached $38 billion
Growth in this market will continue at
an average rate of 28% over the next 5 years
By 2007, drug delivery will account for 39% of all pharmaceutical sales
The fast growth of this
industry sector can be attributed to the following major developments:
- The need for effective delivery of new, revolutionary biopharmaceuticals
- Upcoming patent expirations driving pharma companies to reformulate their products
- New technologies can minimize side effects and lead to better patient compliance
Drug Delivery 2003: New Technologies in the Global Market is arranged to provide an overview of this growing market. Specific attention is
given to the following types of drug delivery:
- Polymers
- Monoclonal Antibodies
- Liposomes
- Oral (controlled release) Delivery
- Pulmonary Delivery
- Injectable Delivery
- Transdermal Delivery
- Transmucosal Delivery
- Implant Technology
Analysis includes the use of charts and graphs measuring product growth and trends within the drug delivery marketplace. Company-specific
information, including sales and revenue figures, licensing arrangements, collaborations, and research and development trends is provided throughout
the report.
Five-year financial forecasts for all types of delivery methods discussed herein are provided as well.
View Cart
